Cervical cancer control in latin america: a call to action
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Federal de Minas Gerais
Descrição
Tipo
Artigo de periódico
Título alternativo
Primeiro orientador
Membros da banca
Resumo
Cervical cancer (CC) is second most common cause of cancer in Latin America and is a leading cause of cancer mortality among
women. In 2015, an estimated 74,488 women will be diagnosed with CC in Latin America and 31,303 will die of the disease. CC mortality is projected to increase by 45% by 2030 despite human papillomavirus (HPV) vaccination and screening efforts. In this setting,
the goal was of the current study was to examine CC control efforts in Latin America and identify deficiencies in these efforts that
could be addressed to reduce CC incidence and mortality. The authors found that HPV vaccination has been introduced in the majority of Latin American countries, and there is now a need to monitor the success (or shortcomings) of these programs and to ensure
that these programs are sustainable. This topic was also reviewed in light of emerging data demonstrating that visual inspection with
acetic acid and HPV DNA testing without Papanicolaou tests have efficacy from a screening perspective and are good alternatives to
cytology-based screening programs. Overall, there is a need to build capacity for CC control in Latin America and the best strategy
will depend on the country/region and must be tailored to meet the needs of the population as well as available resources.
Abstract
Assunto
Neoplasias do Colo do Útero, Papillomavirus Humano, Vacinação, Triagem
Palavras-chave
Câncer cervical, Papilomavírus humano, América Latina, Triagem, Vacinação